Replies to post #509586 on Anavex Life Sciences Corp (AVXL)

[MayoMobile]

My projections were based on ABCLEAR1 as the primary target population. It seems likely Anavex will be approved at re-eval with a narrower indication (ABCLEAR1). GLP-1 failure assists these market penetration forecasts.

For now, nothing has changed.

Curious what Missling will say tomorrow.